# US 2020/0261879 A1 · Method of generating monodisperse emulsions

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0261879 A1
- Document ID: US20200261879A1
- Status: Published application
- Kind: A1
- Application number: 16/649,068
- Filed: 2018-09-28
- Published: 2020-08-20
- Earliest claimed: 2017-09-29
- Assignees: The Regents of the University of California
- Applicants: The Regents of the University of California
- Inventors: Adam R. Abate; Makiko N. Hatori; Leqian Liu; Samuel Kim; Cyrus Modavi
- Web page: https://patentgrep.com/patent/US20200261879A1

## CPC

- B01J 13/08: Simple coacervation, i.e. addition of highly hydrophilic material {(combined with spraying B01J13/043; combined with mechanical division B01J13/04)}
- C12N 15/1075: {by coupling phenotype to genotype, not provided for in other groups of this subclass}
- A61K 9/107: Emulsions {; Emulsion preconcentrates; Micelles (composition of emulsions A61K47/00)}
- A61K 9/127: Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K 9/5015: {Organic compounds, e.g. fats, sugars}
- A61K 9/5089: {Processes}
- A61K 47/34: Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers (A61K47/10 takes precedence)
- B01J 13/04: by physical processes, e.g. drying, spraying
- C09K 23/42: Ethers, e.g. polyglycol ethers of alcohols or phenols
- C12Q 1/6844: Nucleic acid amplification reactions
- C12Q 1/6869: Methods for sequencing
- C09K 23/00: Use of substances as emulsifying, wetting, dispersing, or foam-producing agents
- B01J: CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C09K: MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

The methods described herein, referred to as particle-templated emulsification (PTE), provide an improved approach for generating a monodisperse emulsion that encapsulates target particles of interest without requiring the use of a microfluidic device. Monodisperse droplets may be effectively obtained by using monodisperse particles to template the formation of droplets, which can include, e.g., monodisperse single-emulsion droplets, multiple-emulsion droplets, or Giant Unilamellar Vesicles (GUV), without destroying the integrity of the droplets.

## Claims

### Claim 1

A method for generating a monodisperse emulsion, the method comprising:
combining a plurality of monodisperse template particles with a first fluid to provide a first mixture, wherein the first fluid comprises a plurality of target particles;
combining the first mixture with a second fluid to provide a second mixture, wherein the second fluid is immiscible with the first fluid; and
shearing the second mixture such that a plurality of the monodisperse template particles are encapsulated in a plurality of monodisperse droplets in the second fluid, thereby providing a plurality of monodisperse droplets comprising the first fluid, one of the monodisperse template particles, and one of the plurality of target particles.

### Claim 2 (depends on 1)

The method of claim 1, wherein combining the plurality of monodisperse template particles with the first fluid to provide the first mixture comprises causing a portion of the first fluid to be absorbed by the monodisperse template particles.

### Claim 3 (depends on 1)

The method of claim 1, comprising removing excess first fluid from the first mixture after causing the portion of the first fluid to be absorbed by the monodisperse template particles.

### Claim 4 (depends on 1)

The method of claim 1, wherein combining the plurality of monodisperse template particles with the first fluid to provide the first mixture comprises flowing a portion of the first fluid into the monodisperse template particles.

### Claim 5 (depends on 1, 2, 3, 4)

The method of any one of claims 1-4, wherein the monodisperse template particles comprise a hydrogel.

### Claim 6 (depends on 5)

The method of claim 5, wherein the hydrogel is selected from agarose, alginate, a polyethylene glycol (PEG), a polyacrylamide (PAA), and combinations thereof.

### Claim 7 (depends on 1, 2, 3, 4, 5, 6)

The method of any one of claims 1-6, wherein the first fluid comprises an aqueous phase fluid.

### Claim 8 (depends on 1, 2, 3, 4, 5, 6, 7)

The method of any one of claims 1-7, wherein the second fluid comprises an oil.

### Claim 9 (depends on 8)

The method of claim 8, wherein the oil comprises a fluorocarbon oil, a hydrocarbon oil, or a combination thereof.

### Claim 10 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9)

The method of any one of claims 1-9, wherein the second fluid comprises a surfactant soluble in the second fluid.

### Claim 11 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10)

The method of any one of claims 1-10, wherein the first fluid comprises a surfactant soluble in the first fluid.

### Claim 12 (depends on 11)

The method of claim 11, wherein the surfactant soluble in the first fluid comprises octylphenol ethoxylate and/or octylphenoxypolyethoxyethanol.

### Claim 13 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12)

The method of any one of claims 1-12, wherein the method does not utilize microfluidics.

### Claim 14 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13)

The method of any one of claims 1-13, wherein, after shearing, the second fluid comprises a plurality of droplets that do not comprise one of the monodisperse template particles.

### Claim 15 (depends on 14)

The method of claim 14, comprising enriching for monodisperse droplets comprising monodisperse template particles relative to droplets that do not comprise one of the monodisperse template particles.

### Claim 16 (depends on 15)

The method of claim 15, wherein one or more droplets that do not comprise one of the monodisperse template particles are removed from the monodisperse emulsion by filtration or centrifugation.

### Claim 17 (depends on 14, 15, 16)

The method of any one of claims 14-16, wherein the monodisperse droplets have an average diameter and the plurality of droplets that do not comprise one of the monodisperse template particles have an average diameter which is smaller than the average diameter of the monodisperse template particles.

### Claim 18 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17)

The method of any one of claims 1-17, wherein the shearing comprises flowing the second mixture through a pipette tip, shaking the second mixture with a homogenizer, or shaking the second mixture with a bead beater.

### Claim 19 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18)

The method of any one of claims 1-18, comprising swelling the monodisperse template particles encapsulated in the monodisperse droplets.

### Claim 20 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19)

The method of any one of claims 1-19, wherein the target particles are DNA molecules.

### Claim 21 (depends on 20)

The method of claim 20, wherein the DNA molecules are genomic DNA molecules.

### Claim 22 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19)

The method of any one of claims 1-19, wherein the target particles are RNA molecules.

### Claim 23 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22)

The method of any one of claims 1-22, wherein the target particles are cells.

### Claim 24 (depends on 23)

The method of claim 23, wherein the monodisperse droplets comprise one or more cells per droplet.

### Claim 25 (depends on 23)

The method of claim 23, wherein the monodisperse droplets do not comprise more than one cell per droplet.

### Claim 26 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25)

The method of any one of claims 1-25, further comprising incorporating a cell lysis reagent into the monodisperse droplets.

### Claim 27 (depends on 26)

The method of claim 26, wherein the cell lysis reagent is present in the first mixture prior to encapsulation of the plurality of the monodisperse template particles in the plurality of monodisperse droplets.

### Claim 28 (depends on 26, 27)

The method of claim 26 or 27, wherein the cell lysis reagent does not comprise a detergent.

### Claim 29 (depends on 26, 27, 28)

The method of any one of claims 26-28, wherein the cell lysis reagent comprises proteinase K.

### Claim 30 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29)

The method of any one of claims 1-29, further comprising sorting the monodisperse droplets.

### Claim 31 (depends on 30)

The method of claim 30, wherein the sorting is performed by dielectrophoretic deflection, selective coalescence, fluorescence activated cell sorting (FACS), electrophoresis, acoustic separation, magnetic activated cell sorting (MACS), flow control, or other stimulus used to selectively deflect monodisperse droplets.

### Claim 32 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31)

The method of any one of claims 1-31, wherein the target particles are nucleic acids and wherein the first fluid comprising the plurality of target particles further comprises nucleic acid synthesis reagents, and wherein the nucleic acid synthesis reagents are encapsulated in the monodisperse droplets.

### Claim 33 (depends on 32)

The method of claim 32, comprising subjecting one or more of the monodisperse droplets comprising the first fluid and one or more of the plurality of target particles to nucleic acid synthesis conditions.

### Claim 34 (depends on 32)

The method of claim 32, wherein the nucleic acid synthesis reagents comprise nucleic acid amplification reagents.

### Claim 35 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34)

The method of any one of claims 1-34, comprising subjecting one or more of the monodisperse droplets comprising the first fluid and one or more of the plurality of target particles to nucleic acid amplification conditions.

### Claim 36 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34)

The method of any one of claims 1-34, comprising isolating nucleic acids from one or more of the plurality of monodisperse droplets.

### Claim 37 (depends on 36)

The method of claim 36, comprising isolating nucleic acid synthesis and/or amplification products from one or more of the plurality of monodisperse droplets.

### Claim 38 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37)

The method of any one of claims 1-37, comprising sequencing nucleic acids and/or nucleic acid synthesis and/or amplification products isolated from one or more of the plurality of monodisperse droplets.

### Claim 39 (depends on 34)

The method of claim 34, wherein the nucleic acid amplification reagents comprise Polymerase Chain Reaction (PCR) reagents or Multiple Displacement Amplification (MDA) reagents, and the nucleic acid amplification conditions comprise PCR conditions or MDA conditions, respectively.

### Claim 40 (depends on 34)

The method of claim 34, wherein the nucleic acid amplification reagents comprise isothermal nucleic acid amplification reagents and the nucleic acid amplification conditions comprise isothermal nucleic acid amplification conditions.

### Claim 41 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40)

The method of any one of claims 1-40, wherein the first fluid comprising the plurality of target particles comprises nucleic acid detection reagents, which are encapsulated in the monodisperse droplets.

### Claim 42 (depends on 41)

The method of claim 41, comprising detecting one or more of the target molecules, a portion thereof, a nucleic acid synthesis product thereof, and/or a nucleic acid amplification product thereof by detecting one or more of the detection reagents.

### Claim 43 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42)

The method of any one of claims 1-42, comprising attaching one or more of the target particles, the nucleic acid synthesis reagents, and the nucleic acid detection reagents to one or more of the monodisperse template particles.

### Claim 44 (depends on 43)

The method of claim 43, wherein one or more of the target particles, the nucleic acid synthesis reagents, and the nucleic acid detection reagents are attached to the monodisperse template particles via one or more tethering moieties positioned on or in the monodisperse template particles.

### Claim 45 (depends on 44)

The method of claim 44, wherein the one or more tethering moieties are oligonucleotides which are bound on or in the monodisperse template particles.

### Claim 46 (depends on 44)

The method of claim 44, wherein the one or more tethering moieties are functionalized beads which are encapsulated in the monodisperse template particles.

### Claim 47 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46)

The method of any one of claims 1-46, wherein each of the monodisperse droplets comprise a separate compartment containing a reagent.

### Claim 48 (depends on 47)

The method of claim 47, comprising releasing the reagent from the separate compartment.

### Claim 49 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48)

The method of any one of claims 1-48, wherein the monodisperse template particles have an average volume, and wherein the method comprises shrinking the monodisperse template particles to decrease the average volume.

### Claim 50 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49)

The method of any one of claims 1-49, wherein the monodisperse template particles are a first type of particle, and wherein the method comprises encapsulating one or more of a second type of particle in a droplet with one or more of the first type of particle.

### Claim 51 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50)

The method of any one of claims 1-50, comprising removing excess second fluid from the second mixture following the shearing of the second mixture.

### Claim 52 (depends on 51)

The method of claim 51, wherein removing excess second fluid from the second mixture comprises centrifuging the mixture and removing the supernatant.

### Claim 53 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52)

The method of any one of claims 1-52, comprising combining a third fluid with the second mixture, following the shearing of the second mixture, to produce a third mixture, wherein the third fluid is immiscible with the second fluid.

### Claim 54 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52)

The method of any one of claims 1-52, comprising combining a third fluid with the second mixture, following the shearing of the second mixture, to produce a third mixture, wherein the third fluid is immiscible with the first and second fluids.

### Claim 55 (depends on 53)

The method of claim 53, wherein the third fluid comprises an aqueous phase fluid.

### Claim 56 (depends on 49, 54)

The method of claim 49 or 54, wherein the third fluid comprises an oil.

### Claim 57 (depends on 53, 54, 55, 56)

The method of any one of claims 53-56, wherein the third fluid comprises a surfactant soluble in the third fluid.

### Claim 58 (depends on 53, 54, 55, 56, 57)

The method of any one of claims 53-57, comprising shearing the third mixture to encapsulate the monodisperse template particles in double-emulsion droplets in the third fluid.

### Claim 59 (depends on 53)

The method of any one of claims 53-53, comprising shearing the third mixture to encapsulate one or more of the monodisperse droplets, with or without the monodisperse template particles, in one or more droplets in the third fluid to provide one or more double-emulsion droplets.

### Claim 60 (depends on 53, 54, 55, 56, 57, 58, 59)

The method of any one of claims 53-59, wherein the third fluid comprises a gelling agent.

### Claim 61 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60)

The method of any one of claims 1-60, wherein 75% or more of the monodisperse droplets comprise one, and not more than one, monodisperse template particle.

### Claim 62 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60)

The method of any one of claims 1-60, wherein 85% or more of the monodisperse droplets comprise one, and not more than one, monodisperse template particle.

### Claim 63 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60)

The method of any one of claims 1-60, wherein 95% or more of the monodisperse droplets comprise one, and not more than one, monodisperse template particle.

### Claim 64 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62)

The method of any one of claims 1-62, wherein 75% or more of the monodisperse template particles are encapsulated in monodisperse droplets in the second fluid.

### Claim 65 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62)

The method of any one of claims 1-62, wherein 90% or more of the monodisperse template particles are encapsulated in monodisperse droplets in the second fluid.

### Claim 66 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65)

The method of any one of claims 1-65, wherein the monodisperse template particles comprise a lipophilic polymer.

### Claim 67

A method, comprising:
combining a plurality of monodisperse template particles with a first fluid to provide a first mixture, wherein the first fluid comprises a plurality of cells and a cell-lysis reagent;
combining the first mixture with a second fluid to provide a second mixture, wherein the second fluid is immiscible with the first fluid;
shearing the second mixture such that a plurality of the monodisperse template particles are encapsulated in a plurality of monodisperse droplets in the second fluid, thereby providing a plurality of monodisperse droplets comprising the first fluid, one of the monodisperse template particles, the cell-lysis reagent, and one of the plurality of cells;
maintaining the cell-lysis reagent at a temperature sufficient to prevent activation of the cell lysis reagent until after the plurality of monodisperse droplets are provided; and
following the provision of the plurality of monodisperse droplets, incubating the plurality of monodisperse droplets at a temperature sufficient for activation of the cell-lysis reagent and lysis of the one of the plurality of cells.

### Claim 68 (depends on 67)

The method of claim 67, wherein the cell-lysis reagent comprises proteinase K.

### Claim 69 (depends on 67, 68)

The method of claim 67 or 68, wherein the cell-lysis reagent does not comprise a detergent.

### Claim 70 (depends on 67, 68, 69)

The method of any one of claims 67-69, comprising rupturing the plurality of monodisperse droplets.

### Claim 71 (depends on 67, 68, 69, 70)

The method of any one of claims 67-70, wherein the first fluid comprises a plurality of RNA-capture beads.

### Claim 72 (depends on 67, 68, 69, 70)

The method of any one of claims 67-70, wherein the monodisperse template particles comprise one or more RNA-capture beads incorporated therein.

### Claim 73 (depends on 71, 72)

The method of claim 71 or 72, comprising sequencing RNA molecules captured by the RNA-capture beads.
